Intimation of closure of trading window for the quarter ending 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has informed BSE that its trading window for dealing in company securities will remain closed from January 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending December 31, 2025. The closure applies to Directors, Designated Persons, and their immediate relatives, in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The company has also updated the NSDL portal to freeze PANs of designated persons at the security level. The board meeting date to approve the Q3 FY26 results will be announced separately.
This is a routine quarterly compliance filing and does not signal any material event. Investors should note that insiders cannot trade during this period, and the upcoming Q3 results announcement will be the next key catalyst for the stock.